138 related articles for article (PubMed ID: 5390548)
1. [Clinical application of Sophia-A, combined low-dosage preparation of norethisterone and mestranol].
Akasu F; Akasofu K; Hayashi I; Fujii I; Shimada H
Horumon To Rinsho; 1969 Oct; 17(10):871-5. PubMed ID: 5390548
[No Abstract] [Full Text] [Related]
2. [Treatment of dysmenorrhea with a mixed preparation of norethindrone and mestranol (S-3800C)].
Karasawa Y
Sanfujinka No Jissai; 1968 Oct; 17(10):913-8. PubMed ID: 5755772
[No Abstract] [Full Text] [Related]
3. [Clinical effects of norethisterone and mestrano mixture (Sophid-32) in a low dosage].
Okada K; Yoshizaki S; Ozawa H
Sanfujinka No Jissai; 1970 Jan; 19(1):98-102. PubMed ID: 5467334
[No Abstract] [Full Text] [Related]
4. [Clinical study of S-3800E tablets, a combination of norethindrone and mestranol in a small dosage].
Tokuda G; Murakami A; Higashiyama S; Obata T; Ishihara S
Saishin Igaku; 1969 Mar; 24(3):644-56. PubMed ID: 5772841
[No Abstract] [Full Text] [Related]
5. [Clinical use of combined tablets of norethisterone 1.0 mg and mestranol.05 mg].
Domon H; Washizuka N; Ishikawa M
Horumon To Rinsho; 1969 Feb; 17(2):133-6. PubMed ID: 5815262
[No Abstract] [Full Text] [Related]
6. A new progestogen-estrogen combination for gynecologic therapy and contraception.
Linthorst G
Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282
[No Abstract] [Full Text] [Related]
7. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
Müller R; Kempf HJ; Eckert L
Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
[No Abstract] [Full Text] [Related]
8. [On the influence of oral gestagens on the increased excretion of neutral 17-ketosteroids and 17-hydroxycorticosteroids in anovulatory sexually mature women].
Gitsch E; Friedrich F
Wien Klin Wochenschr; 1967 Nov; 79(44):805-9. PubMed ID: 5589332
[No Abstract] [Full Text] [Related]
9. [Sequential therapy].
Annee Endocrinol; 1967; 19():97-102. PubMed ID: 4173491
[No Abstract] [Full Text] [Related]
10. [Use of an estroprogestinic association (norethindrone 2 mg and mestranol 100 gamma) in dysfunctional gynecologic syndromes].
Capra A; Trompeo P; Garetto A; Campagnoli C
Minerva Ginecol; 1969 Aug; 21(15):967-86. PubMed ID: 5404341
[No Abstract] [Full Text] [Related]
11. [The menstrual cycle after oral contraceptives].
Hauser GA; Girotti M
Geburtshilfe Frauenheilkd; 1967 Jun; 27(6):626-30. PubMed ID: 5592760
[No Abstract] [Full Text] [Related]
12. [On the use of a new synthetic estrogen-progestin combination in the treatment of functional gynecologic disorders].
Fiorino S; Rossi T; Scio A
Quad Clin Ostet Ginecol; 1966 May; 21(5):282-310. PubMed ID: 5988967
[No Abstract] [Full Text] [Related]
13. [Clinical investigations on the usefulness of Lyndiol for contraceptive and therapeutic purposes].
Liebhart S; Trebicka-Kwiatkowska B
Endokrynol Pol; 1966; 17(6):717-28. PubMed ID: 5341992
[No Abstract] [Full Text] [Related]
14. [Cytologic and colposcopic findings before and after administration of ovulation inhibitors].
Loskant G; Heinen G
Zentralbl Gynakol; 1968 May; 90(18):609-13. PubMed ID: 5722983
[No Abstract] [Full Text] [Related]
15. Primary dysmenorrhea: combination vs sequential therapy.
Buttram VC; Kaufman RH
Tex Med; 1969 Aug; 65(8):52-5. PubMed ID: 4185963
[No Abstract] [Full Text] [Related]
16. [Trial use of Sophia-32].
Kanazawa Y
Horumon To Rinsho; 1969 Jul; 17(7):611-4. PubMed ID: 5390067
[No Abstract] [Full Text] [Related]
17. Dysmenorrhoea unrelieved by an oral contraceptive.
Practitioner; 1968 Jun; 200(200):856-9. PubMed ID: 4871666
[No Abstract] [Full Text] [Related]
18. Catamenial pneumothorax. Bilateral occurrence while on suppressive therapy.
Wilhelm JL; Scommegna A
Obstet Gynecol; 1977 Aug; 50(2):227-31. PubMed ID: 876563
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the hormonal activity and progestagenic properties of Ovosiston preparation].
Krzywdziński K; Jedrzejewski M; Teter J
Ginekol Pol; 1969 Jan; 40(1):41-52. PubMed ID: 4181038
[No Abstract] [Full Text] [Related]
20. [Treatment of hormonally induced bleeding abnormalities and psychovegetative disorders with a two-phase preparation].
Warnecke G; Lachnit U
Ther Ggw; 1974 Feb; 113(2):254-5 passim. PubMed ID: 4596827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
